Efficacy of Combined Therapy With Silodosin and Solifenacin in Females With Overactive Bladder

Efficacy of Combined Therapy With Silodosin and Solifenacin in Females With Overactive Bladder

Purpose We aimed to assess the clinical efficacy and safety of combining silodosin and solifenacin for overactive bladder (OAB) in females. Methods A retrospective analysis of 586 females with OAB was conducted. Patients received either combination therapy (silodosin 8 mg + solifenacin 5 mg) or mono...

Full description

Saved in:

Bibliographic Details
Main Authors:	Byeong Jo Jeon, Hyun Kyung Chang, Bum Sik Tae, Jae Young Park, Duck Ki Yoon, Jae Hyun Bae
Format:	Article
Language:	English
Published:	Korean Continence Society 2024-12-01
Series:	International Neurourology Journal
Subjects:	urinary bladder overactive silodosin solifenacin succinate
Online Access:	http://einj.org/upload/pdf/inj-2448374-187.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and Tolerability of Solifenacin Fumarate with Overactive Bladder Patients: A Multicenter Observational Study
by: Jae Hun Shim, et al.
Published: (2021-04-01)

Efficacy and safety of solifenacin for overactive bladder: An updated systematic review and meta-analysis
by: I Gede Yogi Prema Ananda, et al.
Published: (2025-01-01)

Comparison Of Outcome And Side Effects Profile Of Treatment Of Overactive Bladder With Different Classes Of Drugs
by: Nazish Sarfraz, et al.
Published: (2023-12-01)

Treating overactive bladder symptoms after transurethral prostatic surgery for benign prostatic hyperplasia – Which medication to choose?
by: Cheng-Ling Lee, et al.
Published: (2023-01-01)

Effectiveness of Solifenacin versus Mirabegron in the Treatment of Overactive Bladder: A Prospective Cohort Study
by: Shyamali Dutta, et al.
Published: (2025-07-01)

Efficacy of Additional Solifenacin Succinate Therapy for Storage Symptoms in Females with Uncomplicated Lower Urinary Tract Infection: The SOLUTION Randomized Controlled Trial
by: Harrina Erlianti Rahardjo, et al.
Published: (2018-10-01)

Efficacy of Additional Solifenacin Succinate Therapy for Storage Symptoms in Females with Uncomplicated Lower Urinary Tract Infection: The SOLUTION Randomized Controlled Trial
by: Harrina Erlianti Rahardjo, et al.
Published: (2018-10-01)

Efficacy and Safety of Mirabegron Compared to Solifenacin in Treatment of Non-neurogenic Overactive Bladder in Children: A Randomized Controlled Trial
by: Islam Mansour, et al.
Published: (2025-03-01)

Prevalence, impact on quality of life, and predictive factors of coexistence of overactive bladder and underactive bladder in men
by: Noritoshi Sekido, et al.
Published: (2025-07-01)

Does Anticholinergic Burden Influence Therapeutic Success in Patients with Treatment-naïve Overactive Bladder?
by: João Oliveira, et al.
Published: (2025-09-01)

Overactive Bladder: Where We Are and Where We Are Going
by: Charan S. Mohan, et al.
Published: (2021-09-01)

Guidelines for the Treatment of Urinary Incontineence and Overactive Bladder
by: C.F. Heyns, et al.
Published: (2002-03-01)

Neurotrophins and Proneurotrophins as Biomarkers for Overactive Bladder Syndrome in Aging Females
by: Claudia Covarrubias, et al.
Published: (2025-06-01)

The Role of microRNA in Overactive Bladder: Relationship and Clinical Correlation
by: Kürşat Küçüker, et al.
Published: (2025-03-01)

Transvertebral magnetic neuromodulation for the treatment of overactive bladder: 6 months follow-up
by: G V. Kovalev, et al.
Published: (2020-12-01)

Association between overactive bladder and female sexual frequency: a cross-sectional analysis of the National Health and nutrition examination survey data
by: Bo Zhang, et al.
Published: (2025-02-01)

Abnormal Cerebral Perfusion and Functional Connectivity in Women with Overactive Bladder
by: Shichun Chen, et al.
Published: (2025-06-01)

The clinical application of intravesical botulinum toxin A injection in patients with overactive bladder and interstitial cystitis
by: Yuan-Hong Jiang, et al.
Published: (2023-01-01)

Acupuncture combined with mirabegron is efficacious for the treatment of overactive bladder: a prospective randomized controlled trial
by: Deng Xiaolin, et al.
Published: (2025-07-01)

The Management of Children and Adolescents with Overactive Bladder Refractory to Treatment with Parasacral Transcutaneous Electrical Nerve Stimulation
by: Carlos Eduardo Rocha Macedo, et al.
Published: (2025-01-01)

Risk factors, urodynamic characteristics, and distress associated with nocturnal enuresis in overactive bladder -wet women
by: Kuan Chong Ng, et al.
Published: (2025-01-01)

Enantio- and Chemo-Selective HPLC Analysis of Silodosin on an Amylose-Based Chiral Stationary Phase
by: Daniele Sadutto, et al.
Published: (2025-04-01)

New insights into the association between arthritis and overactive bladder in NHANES 2005–2020
by: Yifan Sun, et al.
Published: (2025-02-01)

Two birds with one stone: sustainable smart spectrophotometric methods for concurrent determination of silodosin and mirabegron: application to dosage forms and greenness assessment
by: Khalid M. Badr El-Din, et al.
Published: (2025-03-01)

The role of Kegel exercises in reducing involuntary loss of urine in Overactive Bladder and Mixed Urinary Inconti-nence
by: Lucian Șerbanescu, et al.
Published: (2025-01-01)

Mirabegron in the Management of Overactive Bladder Syndrome in Ghazi Al-Hariri Hospital
by: Hiba H. Razaq, et al.
Published: (2025-04-01)

Multi-center, prospective, non-interventional, observational study on the efficacy and safety of Mirabek® in adult patients with overactive bladder
by: Jee Soo Park, et al.
Published: (2025-01-01)

Association between novel anthropometric indices and overactive bladder: a population-based study
by: Heng Liu, et al.
Published: (2025-01-01)

Intradetrusor OnabotulinumtoxinA outcomes for overactive bladder in older adults
by: Rachel Stading, et al.
Published: (2024-12-01)

Correlation between excessive sugar intake and overactive bladder in children
by: Xu Cui, et al.
Published: (2025-05-01)

Transdermal delivery of tolterodine tartrate for overactive bladder treatment: In vitro and in vivo evaluation
by: Rajabalaya Rajan, et al.
Published: (2017-09-01)

Review of simultaneous treatment with intradetrusor onabotulinumtoxinA injections during transurethral prostate surgery for men with bladder outlet obstruction and overactive bladder
by: Chun-Kai Hsu, et al.
Published: (2025-01-01)

The Effects of Suburethral Tension Adjustable Sling (Remeex system) for Female Urinary Incontinence between Pure Intrinsic Sphincter Deficiency and Intrinsic Sphincter Deficiency with Overactive Bladder: Initial Experience with Propensity Score Matching
by: Sang Wook Lee, et al.
Published: (2022-08-01)

Masks of Chronic Prostatitis: Overactive bladder and Myofascial Syndrome. Case study
by: E. V. Kulchavenya, et al.
Published: (2019-09-01)

The effectiveness of intravesical oxybutynin in the management of overactive bladder: a clinical study
by: Shoeb Alahmad, et al.
Published: (2024-12-01)

THE EFFECT OF INTRAVESICAL ONABOTULINUM TOXIN A TREATMENT ON QUALITY OF LIFE IN PATIENTS WITH OVERACTIVE BLADDER
by: Tuğçe Arslanoğlu, et al.
Published: (2023-03-01)

Early urinary catheter removal in patients undergoing rectal cancer surgery: a randomized controlled trial on silodosin versus no pharmacological treatment on urinary function in the early postoperative period
by: Žilvinas Gricius, et al.
Published: (2025-06-01)

Sustainable UV approaches backed by one step extraction procedure for quantifying the newly released mirabegron and silodosin mixture in urine
by: Ahmed R. Mohamed, et al.
Published: (2025-08-01)

The Efficacy of an Active Medicinal Alkaloid, Berbamine, in Reducing Overactive Bladder Symptoms in a Retinyl Acetate-Induced Model
by: Jan Wróbel, et al.
Published: (2025-01-01)

Relationship between metabolic syndrome and overactive bladder: insights from the NHANES and Mendelian randomization study
by: Zhihao Liu, et al.
Published: (2025-08-01)